Galanthamine hydrobromide NEW
| Price | $52 | $62 | $176 |
| Package | 50mg | 100mg | 500mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-29 |
Product Details
| Product Name: Galanthamine hydrobromide | CAS No.: 1953-04-4 |
| Purity: 98.00% | Supply Ability: 10g |
| Release date: 2026/05/29 |
Product Introduction
Bioactivity
| Name | Galanthamine hydrobromide |
| Description | Galanthamine hydrobromide (Galantamine hydrobromide), a long-acting and centrally active AChE inhibitor (IC50:410 nM), is an allosteric potentiator at neuronal nicotinic ACh receptors. |
| In vitro | Galanthamine has been demonstrated to have an IC50 of 14 nM and 15 nM on AChE in post-mortem human brain frontal cortex and the hippocampus region. Red-cell cholinesterase activity in blood samples from the neurosurgery patients is 10 times more strongly inhibited by Galanthamine in brain tissue samples. [1] Galanthamine (1 μM) activates single channels with conductance's of 18 and 30 pS in outside-out patches excised from dexamethasone mouse fibroblasts (M10 cells). [2] Galanthamine acts as noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma (PC12) cells. Galanthamine (50 μM) activates single-channel currents in outside-out patches excised from clonal PC12 cells. [3] |
| In vivo | Galantamine significantly increases the number of living pyramidal neurons after ischemia-reperfusion injury. Galantamine significantly reduces TUNEL, active caspase-3, and SOD-2 immunoreactivity. The nicotinic antagonist mecamylamine blockes the protective effects of galantamine. The neuroprotective effects of galantamine are preserved even when first administered at 3 hours postischemia. [4] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 35.59 mg/mL (96.64 mM), Sonication is recommended. H2O : 18.2 mg/mL (49.42 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 1 mg/mL (2.72 mM), Sonication is recommended. 10% DMSO+90% Saline : 3.56 mg/mL (9.67 mM), Solution. |
| Keywords | Nicotinic acetylcholine receptors | neurodegenerative | nAChR | Inhibitor | inhibit | Galanthamine hydrobromide | Galanthamine | Galantamine Hydrobromide | Galantamine | disease (AD) | disease | Cholinesterase (ChE) | Alzheimer's | AChE | acetylcholinesterase |
| Inhibitors Related | Adiphenine hydrochloride | Uridine 5'-monophosphate disodium salt | Urethane | Hexamethonium Bromide | Ribavirin | Diethyltoluamide | Adenine | Mitotane | N,N-Dicyclohexylcarbodiimide | Dimethyl sulfoxide | Coumaran | Arecoline |
| Related Compound Libraries | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Pain-Related Compound Library | Approved Drug Library | Anti-Alzheimer's Disease Compound Library | Alkaloid Natural Product Library | Membrane Protein-targeted Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | Ion Channel Targeted Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $52.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-29 | |
| $52.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-05-29 | |
| $3.00 |
VIP1Y
|
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
|
2025-06-21 | |
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | ||
|
VIP2Y
|
Xi an Biohorlden Industry Trade Co Ltd
|
2025-04-17 | ||
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-04-16 | ||
| $10.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-12-02 | ||
| $100.00 |
VIP5Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-21 | |
|
VIP3Y
|
Hangzhou Hyper Chemicals Limited
|
2024-08-07 | ||
|
VIP3Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-05-07 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY